Alumni raised $1.45B in 2022 - Download Free Report Now

Chemel

Minimally invasive needle biosensor for in vivo glucose or lactate monitoring of intensive care patients.

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Chemel plus 5517 other startups.

Start Free 7 Day Trial Now

Learn More About Chemel

Technology/product details

CEO presentation

Competing Startups

More

Companies We Work With